PA Medical News about Salivary Glands Thyroid Neoplasms Amifostine Amifostine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09

Ma C et al. – Amifostine is thought to be a radioprotector of salivary glands used in conjunction with radioiodine therapy. This medication is administered intravenously and was reported to ameliorate the damage of salivary glands caused by radioactive iodine therapy...The authors found only two randomised controlled trials in which the effects of amifostine were compared with placebo. Results from two randomised controlled clinical trials suggest that the amifostine has no significant radioprotective effects on salivary glands in high–dose radioactive iodine treated differentiated thyroid cancer patients. Moreover, no health–related quality of life and other patient–oriented outcomes were evaluated in the two included trials. Randomised controlled clinical trials with low risk of bias investigating patient–oriented outcomes are needed to guide treatment choice.

<< Previous
Dent's disease manifesting as focal glomerulosclerosis: Is it the...

Next >>
Relationship between therapeutic homework and clinical outcomes...

Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: Report of a case
Surgery Today, 10/06/09 Relevance Score: 81%

Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior
BMC Cancer, 11/13/09 Relevance Score: 80%

Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
European Journal of Endocrinology, 10/06/09 Relevance Score: 79%

Development and application of magnetic resonance elastography of the normal and pathological thyroid gland in vivo
Journal of Magnetic Resonance Imaging, 11/09/09 Relevance Score: 68%

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09 Relevance Score: 68%